drag_handle
DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open innovation from Tokyo, where you can experience the intersection of cool and passionate design and technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
Salt reduction technology: Discussion on methods of limiting sodium using yeast extracts to meet consumer demand.
As regulatory pressure to reduce sodium intensifies, food manufacturers face the challenge of reformulating popular products without losing flavor appeal. Summer is a critical period for savory foods like barbecue meats, dips, and salty snacks, making salt reduction strategies especially important for brands seeking to meet health guidelines while satisfying consumer expectations. To explore practical solutions, Food Ingredients First speaks with Daria Pashkova, product and marketing manager at Ohly. The company develops yeast-based ingredients designed to support sodium reduction by preserving savoury flavour profiles in demanding applications such as snacks and marinades.
Comparison of swallowing dynamics between jelly and thickened liquids used for swallowing training in Japan
In this study, we investigated the swallowing dynamics of jelly, thick liquids, and thin liquids in selected stroke patients. The patients were those deemed to have nearly normal swallowing function based on screening tests. Video fluoroscopic examinations were conducted to compare pharyngeal transit time (PTT), pharyngeal delay time (PDT), and laryngeal elevation delay time (LEDT).Among 175 patients (104 men, 71 women, mean age 68.6 ± 12.0 years), 24 (13.7%) experienced aspiration, and significantly longer LEDT was observed during swallowing of thin liquids.In patients who did not experience aspiration, there were no significant differences in PTT during swallowing of jelly, thick liquids, or thin liquids. However, when PTT was analyzed in two stages before and after the passage of jelly through the epiglottis, the former was significantly longer, and the latter was significantly shorter. PDT was significantly longer during swallowing of jelly compared to thick liquids or thin liquids.LEDT was significantly longer during swallowing of thin liquids. Thin liquids may reach the pharynx before achieving the maximum laryngeal elevation, potentially increasing the risk of laryngeal penetration or aspiration during swallowing. On the other hand, thick liquids may prolong the time it takes to reach the pharynx, thereby reducing the risk of aspiration. Additionally, the oral-pharyngeal transit of jelly is prolonged, triggering the swallowing reflex at the epiglottis and allowing it to pass through the hypopharynx after laryngeal closure.
Light and AI-driven flexible robot arm—a new control paradigm that does not require electronic components
A research team at Rice University has developed a flexible robotic arm capable of performing precise movements using only light and AI. The arm employs an innovative method that requires no internal electronic components or wiring, and is remotely controlled by laser light. The arm is made of a light-responsive azobenzene liquid crystal elastomer (LCE). Localized irradiation of blue laser light causes the material to contract and bend, enabling complex movements.Control is achieved using a spatial light modulator (SLM), with a neural network built using machine learning generating light patterns in real time according to the desired motion. This enables advanced movements such as obstacle avoidance and kicking a ball. Elizabeth Blackert, a PhD graduate, commented, “This is the first time in the world that real-time, reconfigurable automatic control has been achieved for light-responsive materials.”This technology is expected to have a wide range of applications, including implantable medical devices and industrial fields requiring delicate object handling. The lightweight structure, which eliminates electronic components, offers superior safety and adaptability, presenting a new design concept for flexible robot control.
British startup BoobyBiome raises €2.8 million for infant health with breast milk microbiome breakthrough
BoobyBiome, a London-based BioTech company advancing the science of breast milk and the microbiome, has raised €2.8 million in Seed funding for its infant feeding solutions in order to scale internationally. The funding round was led by DeepTech investor Empirical Ventures, alongside The Helm, XFactor Ventures, Lavender Ventures, Kayan Ventures, and Evenlode Investment, with angels including Dominic Hollamby, Lord Ara Darzi, Yael Cohen, Vanessa Colomar, and others.
A New Approach to Dark Spot Prevention — New Findings Show Vitamin C Derivative × Sage Extract Suppresses “Chronic Inflammation”
Kobayashi Pharmaceutical, through joint research with Kinki University's Institute of Pharmaceutical Sciences, has revealed that a vitamin C derivative (L-ascorbic acid 2-glucoside) and sage extract suppress the expression of the inflammatory substance “GM-CSF (granulocyte-macrophage colony-stimulating factor)” produced by chronic inflammation caused by UV rays and aging, thereby preventing melanin production. These findings were published in the international academic journal PLOS One on June 10. The study uniquely selected sage extract as a “spot-suppressing ingredient” and verified its mechanism of action using epidermal cells. Both the vitamin C derivative and sage extract were confirmed to prevent excessive melanin production by suppressing GM-CSF expression. Notably, vitamin C derivatives were found to possess a novel action beyond their previously known antioxidant effects and tyrosinase activity inhibition: preventing the production of inflammatory substances. This suggests the potential for a single ingredient to approach dark spots through multiple pathways. (※This part was revised because framing it as suppressing chronic inflammation itself implied it might suppress everything besides GM-CSF.) The company has actively pursued research in dermatological areas such as dark spots and acne. This achievement is part of that effort, emphasizing its commitment to uncovering new insights about existing active ingredients and plant extracts. Moving forward, the company plans to establish unique skincare technologies through its proprietary approach, expanding beyond the combination of vitamin C derivatives and sage extract to include research on other ingredients. Guided by its purpose of “solving overlooked concerns and supporting people's potential,” the company prioritizes consumer-centric research and development. This achievement exemplifies its efforts to discover new value in existing ingredients and expand the frontiers of beauty and health. Moving forward, the company expects to apply these findings to develop new beauty care products.
BloodVitals – Introducing BloodVitals 2025: Effortless & Pain-Free Free Blood Glucose Monitoring Device With Lab-Grade Accuracy
In an era where real-time health data is becoming an essential tool in preventive care, a new at-home monitoring device is drawing widespread attention. BloodVitals, a fingertip pulse oximeter with a sleek, pain-free design, is being introduced as a next-generation solution for tracking blood glucose, blood oxygen saturation (SpO₂) and heart rate with clinical accuracy—without the needles, hassle, or guesswork.
The Rising Popularity of Custom-Made Perfumes Among Male Consumers in Japan
MY ONLY FRAGRANCE offers a service where consumers can customize scents based on their preferences. In-store, fragrance advisors blend scents tailored to each consumer's taste, enabling over 110,430,000 possible combinations to provide each customer with a signature scent for a lifetime.By early July 2025, visitor numbers had increased significantly compared to previous periods, with solo male visits rising fivefold and solo female visits increasing 2.5 times. The brand states that fragrance has become widely embraced as a means of self-expression and self-care, becoming integrated into daily life as part of a growing cultural trend. Currently, MY ONLY FRAGRANCE operates 11 stores nationwide in Japan, located in tourist destinations, urban areas, and commercial facilities.
Ainos to deploy smell-sensing robots across seven Japanese sites
Ainos, Inc. (NASDAQ:AIMD), a micro-cap technology company currently valued at approximately $11 million, announced Tuesday that its partner ugo, Inc. will deploy robots equipped with AI Nose technology at seven industrial sites across Japan, marking what the company calls the first service robots with a sense of smell. According to InvestingPro data, the stock has experienced significant volatility, declining nearly 28% over the past six months. The robots will operate in pharmaceutical manufacturing, facility management, energy operations, power substations, and water treatment plants operated by Japanese corporations, according to a company press release.
LandSkip and Taisei Corporation conduct irradiation tests on “digital windows” for radiation therapy rooms
LandSkip Co., Ltd. (Representative Director: Kazuki Shimomura, hereinafter referred to as “LandSkip”), a provider of digital windows for medical institutions called “Medical Window,” has conducted irradiation tests for the introduction of “digital windows” into a linear accelerator room (radiation therapy room) as part of a joint project with Taisei Corporation (President and CEO: Yoshiro Aikawa, hereinafter referred to as “Taisei”).Through this test, the durability of key equipment was quantitatively evaluated, and safety standards for implementation were clarified. Moving forward, we will use these results to advance the full-scale implementation of the system in medical facilities.
Resmed at SLEEP 2025: Advancing the Future of OSA Diagnosis and Treatment
Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, will attend SLEEP 2025, taking place June 8-11 in Seattle, Washington. At the event, Resmed will present new research on the life-saving cardiovascular benefits of CPAP therapy, including how CPAP therapy use is linked to a 22% lower risk of cardiovascular-related emergency room visits or hospitalizations1. Resmed research will also highlight the impact of CPAP on obstructive sleep apnea (OSA) symptoms and quality of life, the essential role of healthcare providers in supporting patients with OSA, and the increasing and disproportionate burden of OSA among women projected through 2050. In addition, the company will showcase its expanded portfolio of home-based testing solutions designed to simplify and accelerate the path to diagnosis while delivering life-changing health technology that people love.
Scientists map tongue's sweet sensor, may lead to new ways to curb sugar cravings
Scientists have mapped the 3-D structure of the human sweet taste receptor, the molecular machine that allows us to taste sweet things. This could lead to the discovery of new regulators of the receptor that would significantly alter our attraction to and appetite for sugar.
Cognito Therapeutics completes enrollment in landmark Alzheimer’s trial
Cognito Therapeutics announced it has completed enrollment of 670 participants in the HOPE Study, a pivotal clinical trial evaluating the safety and efficacy of its investigational neuromodulation device, Spectris, for patients with Alzheimer’s disease. According to the company, the HOPE Study (NCT05637801) is the largest medical device trial ever focused solely on Alzheimer’s disease. The randomized, double-blind, sham-controlled study spans 70 sites across the U.S. and includes a 12-month treatment phase followed by a 12-month open-label extension. Participants will use the device, which delivers synchronized light and sound stimulation at the 40Hz gamma frequency, in their homes daily.
The Impact of Dietary Intake and Nutritional Status on the Oral Health of Older Adults Living in Care Homes: A Scoping Review
Many elderly people living in nursing homes retain their natural teeth, but maintaining good oral hygiene is difficult and access to dental care is limited, leading to oral health problems. High concentrations of sugars and fermentable carbohydrates may contribute to oral health problems such as dental caries and periodontal disease. This review clarifies the complex relationship between oral health, diet, and nutrition in nursing homes.
DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
DigitalMedical Open Innovation
デジタル・メディカル・オープンイノベーション
BrainEnergy produce DigitalMedical open innovation from Tokyo, where you can experience the intersection of cool and passionate design and technology.
Transform Your Business With Cloud
Looking for the Future
of Health Care
OUR TECHNOLOGY HELPS
YOUR BUSINESS
Our technology will help your business
Technology
Salt reduction technology: Discussion on methods of limiting sodium using yeast extracts to meet consumer demand.
As regulatory pressure to reduce sodium intensifies, food manufacturers face the challenge of reformulating popular products without losing flavor appeal. Summer is a critical period for savory foods like barbecue meats, dips, and salty snacks, making salt reduction strategies especially important for brands seeking to meet health guidelines while satisfying consumer expectations. To explore practical solutions, Food Ingredients First speaks with Daria Pashkova, product and marketing manager at Ohly. The company develops yeast-based ingredients designed to support sodium reduction by preserving savoury flavour profiles in demanding applications such as snacks and marinades.
food ingredients 1st
Comparison of swallowing dynamics between jelly and thickened liquids used for swallowing training in Japan
In this study, we investigated the swallowing dynamics of jelly, thick liquids, and thin liquids in selected stroke patients. The patients were those deemed to have nearly normal swallowing function based on screening tests. Video fluoroscopic examinations were conducted to compare pharyngeal transit time (PTT), pharyngeal delay time (PDT), and laryngeal elevation delay time (LEDT).Among 175 patients (104 men, 71 women, mean age 68.6 ± 12.0 years), 24 (13.7%) experienced aspiration, and significantly longer LEDT was observed during swallowing of thin liquids.In patients who did not experience aspiration, there were no significant differences in PTT during swallowing of jelly, thick liquids, or thin liquids. However, when PTT was analyzed in two stages before and after the passage of jelly through the epiglottis, the former was significantly longer, and the latter was significantly shorter. PDT was significantly longer during swallowing of jelly compared to thick liquids or thin liquids.LEDT was significantly longer during swallowing of thin liquids. Thin liquids may reach the pharynx before achieving the maximum laryngeal elevation, potentially increasing the risk of laryngeal penetration or aspiration during swallowing. On the other hand, thick liquids may prolong the time it takes to reach the pharynx, thereby reducing the risk of aspiration. Additionally, the oral-pharyngeal transit of jelly is prolonged, triggering the swallowing reflex at the epiglottis and allowing it to pass through the hypopharynx after laryngeal closure.
Scientific Reports
Light and AI-driven flexible robot arm—a new control paradigm that does not require electronic components
A research team at Rice University has developed a flexible robotic arm capable of performing precise movements using only light and AI. The arm employs an innovative method that requires no internal electronic components or wiring, and is remotely controlled by laser light. The arm is made of a light-responsive azobenzene liquid crystal elastomer (LCE). Localized irradiation of blue laser light causes the material to contract and bend, enabling complex movements.Control is achieved using a spatial light modulator (SLM), with a neural network built using machine learning generating light patterns in real time according to the desired motion. This enables advanced movements such as obstacle avoidance and kicking a ball. Elizabeth Blackert, a PhD graduate, commented, “This is the first time in the world that real-time, reconfigurable automatic control has been achieved for light-responsive materials.”This technology is expected to have a wide range of applications, including implantable medical devices and industrial fields requiring delicate object handling. The lightweight structure, which eliminates electronic components, offers superior safety and adaptability, presenting a new design concept for flexible robot control.
Rice University
British startup BoobyBiome raises €2.8 million for infant health with breast milk microbiome breakthrough
BoobyBiome, a London-based BioTech company advancing the science of breast milk and the microbiome, has raised €2.8 million in Seed funding for its infant feeding solutions in order to scale internationally. The funding round was led by DeepTech investor Empirical Ventures, alongside The Helm, XFactor Ventures, Lavender Ventures, Kayan Ventures, and Evenlode Investment, with angels including Dominic Hollamby, Lord Ara Darzi, Yael Cohen, Vanessa Colomar, and others.
EU-Startups
A New Approach to Dark Spot Prevention — New Findings Show Vitamin C Derivative × Sage Extract Suppresses “Chronic Inflammation”
Kobayashi Pharmaceutical, through joint research with Kinki University's Institute of Pharmaceutical Sciences, has revealed that a vitamin C derivative (L-ascorbic acid 2-glucoside) and sage extract suppress the expression of the inflammatory substance “GM-CSF (granulocyte-macrophage colony-stimulating factor)” produced by chronic inflammation caused by UV rays and aging, thereby preventing melanin production. These findings were published in the international academic journal PLOS One on June 10. The study uniquely selected sage extract as a “spot-suppressing ingredient” and verified its mechanism of action using epidermal cells. Both the vitamin C derivative and sage extract were confirmed to prevent excessive melanin production by suppressing GM-CSF expression. Notably, vitamin C derivatives were found to possess a novel action beyond their previously known antioxidant effects and tyrosinase activity inhibition: preventing the production of inflammatory substances. This suggests the potential for a single ingredient to approach dark spots through multiple pathways. (※This part was revised because framing it as suppressing chronic inflammation itself implied it might suppress everything besides GM-CSF.) The company has actively pursued research in dermatological areas such as dark spots and acne. This achievement is part of that effort, emphasizing its commitment to uncovering new insights about existing active ingredients and plant extracts. Moving forward, the company plans to establish unique skincare technologies through its proprietary approach, expanding beyond the combination of vitamin C derivatives and sage extract to include research on other ingredients. Guided by its purpose of “solving overlooked concerns and supporting people's potential,” the company prioritizes consumer-centric research and development. This achievement exemplifies its efforts to discover new value in existing ingredients and expand the frontiers of beauty and health. Moving forward, the company expects to apply these findings to develop new beauty care products.
DxMedical Cloud™︎
BloodVitals – Introducing BloodVitals 2025: Effortless & Pain-Free Free Blood Glucose Monitoring Device With Lab-Grade Accuracy
In an era where real-time health data is becoming an essential tool in preventive care, a new at-home monitoring device is drawing widespread attention. BloodVitals, a fingertip pulse oximeter with a sleek, pain-free design, is being introduced as a next-generation solution for tracking blood glucose, blood oxygen saturation (SpO₂) and heart rate with clinical accuracy—without the needles, hassle, or guesswork.
GlobeNewswire
The Rising Popularity of Custom-Made Perfumes Among Male Consumers in Japan
MY ONLY FRAGRANCE offers a service where consumers can customize scents based on their preferences. In-store, fragrance advisors blend scents tailored to each consumer's taste, enabling over 110,430,000 possible combinations to provide each customer with a signature scent for a lifetime.By early July 2025, visitor numbers had increased significantly compared to previous periods, with solo male visits rising fivefold and solo female visits increasing 2.5 times. The brand states that fragrance has become widely embraced as a means of self-expression and self-care, becoming integrated into daily life as part of a growing cultural trend. Currently, MY ONLY FRAGRANCE operates 11 stores nationwide in Japan, located in tourist destinations, urban areas, and commercial facilities.
Cosmetics Design Asia
Ainos to deploy smell-sensing robots across seven Japanese sites
Ainos, Inc. (NASDAQ:AIMD), a micro-cap technology company currently valued at approximately $11 million, announced Tuesday that its partner ugo, Inc. will deploy robots equipped with AI Nose technology at seven industrial sites across Japan, marking what the company calls the first service robots with a sense of smell. According to InvestingPro data, the stock has experienced significant volatility, declining nearly 28% over the past six months. The robots will operate in pharmaceutical manufacturing, facility management, energy operations, power substations, and water treatment plants operated by Japanese corporations, according to a company press release.
Investing.com
LandSkip and Taisei Corporation conduct irradiation tests on “digital windows” for radiation therapy rooms
LandSkip Co., Ltd. (Representative Director: Kazuki Shimomura, hereinafter referred to as “LandSkip”), a provider of digital windows for medical institutions called “Medical Window,” has conducted irradiation tests for the introduction of “digital windows” into a linear accelerator room (radiation therapy room) as part of a joint project with Taisei Corporation (President and CEO: Yoshiro Aikawa, hereinafter referred to as “Taisei”).Through this test, the durability of key equipment was quantitatively evaluated, and safety standards for implementation were clarified. Moving forward, we will use these results to advance the full-scale implementation of the system in medical facilities.
PR TIMES
Resmed at SLEEP 2025: Advancing the Future of OSA Diagnosis and Treatment
Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, will attend SLEEP 2025, taking place June 8-11 in Seattle, Washington. At the event, Resmed will present new research on the life-saving cardiovascular benefits of CPAP therapy, including how CPAP therapy use is linked to a 22% lower risk of cardiovascular-related emergency room visits or hospitalizations1. Resmed research will also highlight the impact of CPAP on obstructive sleep apnea (OSA) symptoms and quality of life, the essential role of healthcare providers in supporting patients with OSA, and the increasing and disproportionate burden of OSA among women projected through 2050. In addition, the company will showcase its expanded portfolio of home-based testing solutions designed to simplify and accelerate the path to diagnosis while delivering life-changing health technology that people love.
Resmed
Scientists map tongue's sweet sensor, may lead to new ways to curb sugar cravings
Scientists have mapped the 3-D structure of the human sweet taste receptor, the molecular machine that allows us to taste sweet things. This could lead to the discovery of new regulators of the receptor that would significantly alter our attraction to and appetite for sugar.
ScienceDaily
Cognito Therapeutics completes enrollment in landmark Alzheimer’s trial
Cognito Therapeutics announced it has completed enrollment of 670 participants in the HOPE Study, a pivotal clinical trial evaluating the safety and efficacy of its investigational neuromodulation device, Spectris, for patients with Alzheimer’s disease. According to the company, the HOPE Study (NCT05637801) is the largest medical device trial ever focused solely on Alzheimer’s disease. The randomized, double-blind, sham-controlled study spans 70 sites across the U.S. and includes a 12-month treatment phase followed by a 12-month open-label extension. Participants will use the device, which delivers synchronized light and sound stimulation at the 40Hz gamma frequency, in their homes daily.
Medical Economics
The Impact of Dietary Intake and Nutritional Status on the Oral Health of Older Adults Living in Care Homes: A Scoping Review
Many elderly people living in nursing homes retain their natural teeth, but maintaining good oral hygiene is difficult and access to dental care is limited, leading to oral health problems. High concentrations of sugars and fermentable carbohydrates may contribute to oral health problems such as dental caries and periodontal disease. This review clarifies the complex relationship between oral health, diet, and nutrition in nursing homes.
National Institutes of Health (NIH) (.gov)